• / Free eNewsletters & Magazine
  • / My Account
Home>EU Approves AstraZeneca Pulmonary Disease Inhaled Treatment

EU Approves AstraZeneca Pulmonary Disease Inhaled Treatment

3party Content

Mon, 24 Nov 2014

By Ed Ballard LONDON--AstraZeneca PLC (AZN.LN) Monday said European regulators have approved Duaklir Genuair, an inhaler treatment for chronic obstructive pulmonary disease. The European Commission cleared the drug for use by adults after studies of its effects on more than 2,000 patients in 11
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.